Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin- neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome

Journal of Infectious Diseases

Volumn 180, Issue 2, 1999, Pages 410-418

  Eriksson, Björn K G ^a,b   Andersson, Jan ^a   Holm, Stig E ^b   Norgren, Mari ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSTATIC AGENT; EXOTOXIN; NEUTRALIZING ANTIBODY;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYSIPELAS; FEMALE; GENETIC VARIABILITY; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROTYPING; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BACTEREMIA; BACTERIAL PROTEINS; CHILD, PRESCHOOL; ERYSIPELAS; EXOTOXINS; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEUTRALIZATION TESTS; PEPTIDE HYDROLASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTYPING; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VARIATION (GENETICS);

EID: 0033509164     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314872     Document Type: Article

References (40)

1. 1. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316:421-7.
2. 2. Colman G, Tanna A, Efstratiou A, Gaworzewska ET. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 1993; 39:165-78.
3. 3. Martin PR, Hoiby EA. Streptococcal serogroup A epidemic in Norway. Scand J Infect Dis 1990; 22:421-9.
4. 4. Strömberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 1991; 164:595-8.
5. 5. Andersen MM, Ronne T. Group A streptococcal bacteremias in Denmark 1987-89. J Infect 1995; 31:33-7.
6. 6. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7.
7. 7. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock like syndrome. A retrospective population-based study. JAMA 1993; 269:384-9.
8. 8. Demers B, Simor AE, Vellend H, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993; 16: 792-800.
9. 9. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336:1167-71.
10. 10. Cone LA, Woodard DR, Schlieverl PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987; 317:146-9.
11. 11. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993; 269:390-1.
12. 12. Kaplan EL. Recent epidemiology of group A streptococcal infections in North America and abroad: an overview. Pediatrics 1996; 97:945-8.
13. 13. Cleary PP, Kaplan EL, Handley JP, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992; 339: 518-21.
14. 14. Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selander RK. Streptococcus pyogenes causing toxic-shock like syndrome and other invasive disease: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 1991; 88:2668-72.
15. 15. Musser JM, Kapur V, Kanjilal S, et al. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J Infect Dis 1993; 167:337-46.
16. 16. Holm SE, Norrby A, Bergholm AM, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992; 166:31-7.
17. 17. Nelson K, Schlievert PM, Selander RK, Musser JJ. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J Exp Med 1991; 174:1271-4.
18. 18. Kline JB, Collins CM. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect Immun 1996; 64: 861-9.
19. 19. Muotiala A, Seppälä H, Huovinen P, Vuopio-Varkila J. Molecular comparison of group A streptococci of TIMI serotype from invasive and non-invasive infections in Finland. J Infect Dis 1997; 175:392-9.
20. 20. Chaussee MS, Liu J, Stevens DL, Ferretti JJ. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis 1996; 173:901-8.
21. 21. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335:547-54.
22. 22. Norrby-Teglund A, Pauksens K, Holm SE, Norgren M. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestations of disease. J Infect Dis 1994; 170:585-91.
23. 23. Eriksson BKG, Andersson J, Holm SE, Norgren M. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis 1998; 27:1428-36.
24. 24. Eriksson B, Jorup-Rönström C, Karkkonen K, Sjöblom AC, Holm SE. Erysipelas: clinical and bacteriological spectrum and serological aspects. Clin Infect Dis 1996; 23:1091-8
25. 25. Weeks CR, Ferretti JJ. Nucleotide sequence of the type A streptococcal pyrogenic exotoxin (erythrogenic toxin) gene from Streptococcus pyogenes bacteriophage T12. Infect Immun 1986; 52:144-50.
26. 26. Johnston KH, Chaiban JE, Wheeler JC. Analysis of the variable domain of the streptokinase gene from streptococci associated with post streptococcal glomerulonephritis. In: Orfieci G, ed. New perspectives on streptococci and streptococcal infections. Stuttgart, Germany: Gustav Fischer Verlag 1991:339-41.
27. 27. Chapnik EK, Gradon JD, Lutwick LI, et al. Streptococcal toxic shock syndrome due to noninvasive pharyngitis. Clin Infect Dis 1992; 14:1074-7.
28. 28. Bartter T, Dascal A, Carroll K, Culey FJ, "Toxic strep syndrome": a manifestation of group A streptococcal infection. Arch Intern Med 1988; 148: 1421-4.
29. 29. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996; 34:953-8.
30. 30. Österlund A. Epidemiological observations on Streptococcus pyogenes serotype TI in Uppsala county, Sweden 1989 95. APMIS 1996; 104:168-70.
31. 31. Schlievert PM. Role of superantigens in human disease. J Infect Dis 1993; 167:997-1002.
32. 32. Norrby-Teglund A, Norgren M, Holm SE, Andersson U, Andersson J. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun 1994; 62:3731-8.
33. 33. Xu S, Collins CM. Temperature regulation of the streptococcal pyrogenic exotoxin A encoding gene (speA). Infect Immun 1996; 64:5399-402.
34. 34. Cleary PP, McLandsborough L, Ikeda L, Clue D, Krawczak J, Lang H, High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in MI group A streptococci. Mol Microbiol 1998; 12:157-67.
35. 35. Chaussee MS, Philips ER, Ferretti JJ. Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion. Infect Immun 1997; 65:1956-9.
36. 36. Talkington D, Schwartz B, Black CM, et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993; 61:3369-74.
37. 37. Herward H, Collin M, Muller-Esterl W, Björck L. Streptococcal cysteine proteinase releases kinins: a novel virulence mechanism. J Exp Med 1996; 184:665-73.
38. 38. Norrby-Teglund A, Newton D, Kotb M, Holm SE, Norgren M. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun 1994; 62:5527-33.
39. 39. Cockerill FR III, Thompson RL, Musser JM, et al. Molecular, serological and clinical features of 16 consecutive cases of invasive streptococcal disease. Clin Infect Dis 1998; 26:1448-58.
40. 40. Hsueh PR, Wu JJ, Tsai PJ, Liu JW, Chuang YC, Luh KT. Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis 1998; 26:584-9.